Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Refined risk stratification for thoracoscopic lobectomy or segmentectomy.

Zhang R, Dippon J, Friedel G.

J Thorac Dis. 2019 Jan;11(1):222-230. doi: 10.21037/jtd.2018.12.44.

2.

Preoperative serum lactate dehydrogenase level as a predictor of major complications following thoracoscopic lobectomy: a propensity-adjusted analysis.

Zhang R, Kyriss T, Dippon J, Boedeker E, Friedel G.

Eur J Cardiothorac Surg. 2019 Feb 11. doi: 10.1093/ejcts/ezz027. [Epub ahead of print]

PMID:
30753382
3.

Strong Associations Between Inflammation, Pruritus and Mental Health in Dialysis Patients.

Schricker S, Heider T, Schanz M, Dippon J, Alscher MD, Weiss H, Mettang T, Kimmel M.

Acta Derm Venereol. 2019 May 1;99(6):524-529. doi: 10.2340/00015555-3128.

4.

Urinary [TIMP-2]·[IGFBP7]-guided randomized controlled intervention trial to prevent acute kidney injury in the emergency department.

Schanz M, Wasser C, Allgaeuer S, Schricker S, Dippon J, Alscher MD, Kimmel M.

Nephrol Dial Transplant. 2018 Jun 28. doi: 10.1093/ndt/gfy186. [Epub ahead of print]

PMID:
29961888
5.

Impact of comorbidity burden on morbidity following thoracoscopic lobectomy: a propensity-matched analysis.

Zhang R, Kyriss T, Dippon J, Ciupa S, Boedeker E, Friedel G.

J Thorac Dis. 2018 Mar;10(3):1806-1814. doi: 10.21037/jtd.2018.02.62.

6.

Is Mistletoe Treatment Beneficial in Invasive Breast Cancer? A New Approach to an Unresolved Problem.

Fritz P, Dippon J, Müller S, Goletz S, Trautmann C, Pappas X, Ott G, Brauch H, Schwab M, Winter S, Mürdter T, Brinkmann F, Faisst S, Rössle S, Gerteis A, Friedel G.

Anticancer Res. 2018 Mar;38(3):1585-1593.

PMID:
29491089
7.

A prospective randomized experimental study to investigate the peritoneal adhesion formation after waterjet injection and argon plasma coagulation (HybridAPC) in a rat model.

Kraemer B, Scharpf M, Keckstein S, Dippon J, Tsaousidis C, Brunecker K, Enderle MD, Neugebauer A, Nuessle D, Fend F, Brucker S, Taran FA, Kommoss S, Rothmund R.

Arch Gynecol Obstet. 2018 Apr;297(4):961-967. doi: 10.1007/s00404-018-4661-4. Epub 2018 Jan 23.

PMID:
29362925
8.

American Society of Anesthesiologists physical status facilitates risk stratification of elderly patients undergoing thoracoscopic lobectomy.

Zhang R, Kyriss T, Dippon J, Hansen M, Boedeker E, Friedel G.

Eur J Cardiothorac Surg. 2018 May 1;53(5):973-979. doi: 10.1093/ejcts/ezx436.

PMID:
29228138
9.

Impact of an in-Hospital Patient Education Program on Choice of Renal Replacement Modality in Unplanned Dialysis Initiation.

Schanz M, Ketteler M, Heck M, Dippon J, Alscher MD, Kimmel M.

Kidney Blood Press Res. 2017;42(5):865-876. doi: 10.1159/000484531. Epub 2017 Nov 21.

10.

Renal effects of metallothionein induction by zinc in vitro and in vivo.

Schanz M, Schaaf L, Dippon J, Biegger D, Fritz P, Alscher MD, Kimmel M.

BMC Nephrol. 2017 Mar 16;18(1):91. doi: 10.1186/s12882-017-0503-z.

11.

The Influence of Thyroid Function, Inflammation, and Obesity on Risk Prediction of Acute Kidney Injury by Cystatin C in the Emergency Department.

Schanz M, Pannes D, Dippon J, Wasser C, Alscher MD, Kimmel M.

Kidney Blood Press Res. 2016;41(5):604-613. Epub 2016 Sep 1.

12.

Smoking Is a Risk Factor for Severe Acute Kidney Injury in Hantavirus-Induced Nephropathia Epidemica.

Kitterer D, Segerer S, Dippon J, Alscher MD, Braun N, Latus J.

Nephron. 2016;134(2):89-94. Epub 2016 Jul 8.

PMID:
27388481
13.

Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.

Schroth W, Winter S, Büttner F, Goletz S, Faißt S, Brinkmann F, Saladores P, Heidemann E, Ott G, Gerteis A, Alscher MD, Dippon J, Schwab M, Brauch H, Fritz P.

Breast Cancer Res Treat. 2016 Jan;155(1):85-97. doi: 10.1007/s10549-015-3651-5. Epub 2015 Dec 9.

PMID:
26650824
14.

C-reactive protein levels in combination with abdominal CT scans is a useful tool to predict the macroscopic appearance in late-stage EPS patients prior to surgery.

Kitterer D, Segerer S, Steurer W, Dippon J, Geissler A, Ulmer C, Braun N, Alscher MD, Latus J.

Int J Nephrol Renovasc Dis. 2015 Aug 13;8:83-90. doi: 10.2147/IJNRD.S84910. eCollection 2015.

15.

Clinical course and long-term outcome of hantavirus-associated nephropathia epidemica, Germany.

Latus J, Schwab M, Tacconelli E, Pieper FM, Wegener D, Dippon J, Müller S, Zakim D, Segerer S, Kitterer D, Priwitzer M, Mezger B, Walter-Frank B, Corea A, Wiedenmann A, Brockmann S, Pöhlmann C, Alscher MD, Braun N.

Emerg Infect Dis. 2015 Jan;21(1):76-83. doi: 10.3201/eid2101.140861.

16.

Polyuria in Hantavirus Infection Reflects Disease Severity and Is Associated with Prolonged Hospital Stay: A Systematic Analysis of 335 Patients from Southern Germany.

Latus J, Kitterer D, Dippon J, Müller S, Artunc F, Segerer S, Alscher MD, Braun N.

Nephron Exp Nephrol. 2014 Dec 13. [Epub ahead of print]

PMID:
25531933
17.

Acute kidney injury and tools for risk-stratification in 456 patients with hantavirus-induced nephropathia epidemica.

Latus J, Schwab M, Tacconelli E, Pieper FM, Wegener D, Rettenmaier B, Schwab A, Hoffmann L, Dippon J, Müller S, Fritz P, Zakim D, Segerer S, Kitterer D, Kimmel M, Gußmann K, Priwitzer M, Mezger B, Walter-Frank B, Corea A, Wiedenmann A, Brockmann S, Pöhlmann C, Alscher MD, Braun N.

Nephrol Dial Transplant. 2015 Feb;30(2):245-51. doi: 10.1093/ndt/gfu319. Epub 2014 Oct 13.

18.

Tubular breast cancer. A retrospective study.

Fritz P, Bendrat K, Sonnenberg M, Trautmann C, Ott G, Heidemann E, Brinkmann F, Faisst S, Gerteis A, Brauch H, Schwab M, Lindner C, Friedrichs K, Alscher MD, Dippon J, Niendorf A.

Anticancer Res. 2014 Jul;34(7):3647-56.

PMID:
24982382
19.

Postoperative survival of lung cancer patients: are there predictors beyond TNM?

Friedel G, Fritz P, Goletz S, Kristen R, Brinkmann F, Dierkesmann R, Schwab M, Ott G, Dippon J, Alscher MD.

Anticancer Res. 2013 Apr;33(4):1609-19.

PMID:
23564805
20.

Analysis of α-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism.

Latus J, Lehmann R, Roesel M, Fritz P, Braun N, Ulmer C, Steurer W, Biegger D, Ott G, Dippon J, Alscher MD, Kimmel M.

Kidney Blood Press Res. 2013;37(1):84-94. doi: 10.1159/000343403. Epub 2013 Mar 29.

21.

Involvement of α-klotho, fibroblast growth factor-, vitamin-D- and calcium-sensing receptor in 53 patients with primary hyperparathyroidism.

Latus J, Lehmann R, Roesel M, Fritz P, Braun N, Ulmer C, Steurer W, Biegger D, Ott G, Dippon J, Alscher MD, Kimmel M.

Endocrine. 2013 Aug;44(1):255-63. doi: 10.1007/s12020-013-9881-6. Epub 2013 Jan 20.

PMID:
23334987
22.

Histological criteria for encapsulating peritoneal sclerosis - a standardized approach.

Braun N, Fritz P, Ulmer C, Latus J, Kimmel M, Biegger D, Ott G, Reimold F, Thon KP, Dippon J, Segerer S, Alscher MD.

PLoS One. 2012;7(11):e48647. doi: 10.1371/journal.pone.0048647. Epub 2012 Nov 7.

23.

Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon.

Ehmann R, Boedeker E, Friedrich U, Sagert J, Dippon J, Friedel G, Walles T.

Eur Respir J. 2012 Mar;39(3):669-76. doi: 10.1183/09031936.00051711. Epub 2011 Aug 18.

24.

Clinical impacts of histological subtyping primary breast cancer.

Fritz P, Klenk S, Goletz S, Gerteis A, Simon W, Brinkmann F, Heidemann E, Lütttgen E, Ott G, Alscher MD, Schwab M, Dippon J.

Anticancer Res. 2010 Dec;30(12):5137-44.

PMID:
21187502
25.

Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.

Friedel G, Budach W, Dippon J, Spengler W, Eschmann SM, Pfannenberg C, Al-Kamash F, Walles T, Aebert H, Kyriss T, Veit S, Kimmich M, Bamberg M, Kohlhaeufl M, Steger V, Hehr T.

J Clin Oncol. 2010 Feb 20;28(6):942-8. doi: 10.1200/JCO.2008.21.7810. Epub 2010 Jan 25.

PMID:
20100967
26.

Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation.

Herdeg C, Göhring-Frischholz K, Haase KK, Geisler T, Zürn C, Hartmann U, Wöhrle J, Nusser T, Dippon J, May AE, Gawaz M.

Circ Cardiovasc Interv. 2009 Aug;2(4):294-301. doi: 10.1161/CIRCINTERVENTIONS.108.827865.108.827865. Epub 2009 Jul 22.

PMID:
20031731
27.

Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.

Steger V, Walles T, Kosan B, Walker T, Kyriss T, Veit S, Dippon J, Friedel G.

Ann Thorac Surg. 2009 Jun;87(6):1676-83. doi: 10.1016/j.athoracsur.2009.03.068.

PMID:
19463576
28.

Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumors.

Justenhoven C, Pierl CB, Haas S, Fischer HP, Hamann U, Baisch C, Harth V, Spickenheuer A, Rabstein S, Vollmert C, Illig T, Pesch B, Brüning T, Dippon J, Ko YD, Brauch H.

Int J Cancer. 2009 May 1;124(9):2077-81. doi: 10.1002/ijc.24198.

29.

CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation.

Geisler T, Schaeffeler E, Dippon J, Winter S, Buse V, Bischofs C, Zuern C, Moerike K, Gawaz M, Schwab M.

Pharmacogenomics. 2008 Sep;9(9):1251-9. doi: 10.2217/14622416.9.9.1251.

30.

Statins do not adversely affect post-interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapy.

Geisler T, Zürn C, Paterok M, Göhring-Frischholz K, Bigalke B, Stellos K, Seizer P, Kraemer BF, Dippon J, May AE, Herdeg C, Gawaz M.

Eur Heart J. 2008 Jul;29(13):1635-43. doi: 10.1093/eurheartj/ehn212. Epub 2008 May 24.

PMID:
18503057
31.

Full-thickness resection with myocutaneous flap reconstruction for locally recurrent breast cancer.

Friedel G, Kuipers T, Dippon J, Al-Kammash F, Walles T, Kyriss T, Veit S, Greulich M, Steger V.

Ann Thorac Surg. 2008 Jun;85(6):1894-900. doi: 10.1016/j.athoracsur.2008.02.012.

PMID:
18498790
32.

Analysis of the distribution of functionally relevant rare codons.

Widmann M, Clairo M, Dippon J, Pleiss J.

BMC Genomics. 2008 May 5;9:207. doi: 10.1186/1471-2164-9-207.

33.

Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group.

Schwab M, Zanger UM, Marx C, Schaeffeler E, Klein K, Dippon J, Kerb R, Blievernicht J, Fischer J, Hofmann U, Bokemeyer C, Eichelbaum M; German 5-FU Toxicity Study Group.

J Clin Oncol. 2008 May 1;26(13):2131-8. doi: 10.1200/JCO.2006.10.4182. Epub 2008 Feb 25.

PMID:
18299612
34.

Morbidity and mortality after pneumonectomy in smokers with NSCLC.

Kirschbaum A, Kyriss T, Dippon J, Friedel G.

Thorac Surg Sci. 2008 Aug 25;5:Doc01.

35.

Effects of rifampicin on global gene expression in human small intestine.

Oscarson M, Burk O, Winter S, Schwab M, Wolbold R, Dippon J, Eichelbaum M, Meyer UA.

Pharmacogenet Genomics. 2007 Nov;17(11):907-18.

PMID:
18075461
36.

The CYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer.

Justenhoven C, Pierl CB, Haas S, Fischer HP, Baisch C, Hamann U, Harth V, Pesch B, Brüning T, Vollmert C, Illig T, Dippon J, Ko YD, Brauch H.

Breast Cancer Res Treat. 2008 Sep;111(1):171-7. Epub 2007 Oct 6.

PMID:
17922187
37.

Breast cancer: a candidate gene approach across the estrogen metabolic pathway.

Justenhoven C, Hamann U, Schubert F, Zapatka M, Pierl CB, Rabstein S, Selinski S, Mueller T, Ickstadt K, Gilbert M, Ko YD, Baisch C, Pesch B, Harth V, Bolt HM, Vollmert C, Illig T, Eils R, Dippon J, Brauch H.

Breast Cancer Res Treat. 2008 Mar;108(1):137-49. Epub 2007 Jun 23.

PMID:
17588204
38.

Systematic interpretation of microarray data using experiment annotations.

Fellenberg K, Busold CH, Witt O, Bauer A, Beckmann B, Hauser NC, Frohme M, Winter S, Dippon J, Hoheisel JD.

BMC Genomics. 2006 Dec 20;7:319.

39.

Presentation, patterns of myocardial damage, and clinical course of viral myocarditis.

Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock CT, Klingel K, Kandolf R, Sechtem U.

Circulation. 2006 Oct 10;114(15):1581-90. Epub 2006 Oct 2.

PMID:
17015795
40.

A novel functional polymorphism in the transforming growth factor-beta2 gene promoter and tumor progression in breast cancer.

Beisner J, Buck MB, Fritz P, Dippon J, Schwab M, Brauch H, Zugmaier G, Pfizenmaier K, Knabbe C.

Cancer Res. 2006 Aug 1;66(15):7554-61.

41.

Creatinine measurements by the Jaffé method in different peritoneal dialysis fluids exhibit wide variation.

Alscher DM, Muerdter TE, Knabbe C, Kuhlmann U, Dippon J, Hoffmann JE, Lage C.

Perit Dial Int. 2006 Mar-Apr;26(2):280-3. No abstract available.

PMID:
16623438
42.

Smad4-expression is decreased in breast cancer tissues: a retrospective study.

Stuelten CH, Buck MB, Dippon J, Roberts AB, Fritz P, Knabbe C.

BMC Cancer. 2006 Jan 26;6:25.

43.

c-erbB2 and topoisomerase IIalpha protein expression independently predict poor survival in primary human breast cancer: a retrospective study.

Fritz P, Cabrera CM, Dippon J, Gerteis A, Simon W, Aulitzky WE, van der Kuip H.

Breast Cancer Res. 2005;7(3):R374-84. Epub 2005 Mar 21.

44.

Integration of GO annotations in Correspondence Analysis: facilitating the interpretation of microarray data.

Busold CH, Winter S, Hauser N, Bauer A, Dippon J, Hoheisel JD, Fellenberg K.

Bioinformatics. 2005 May 15;21(10):2424-9. Epub 2005 Mar 3.

PMID:
15746280
45.

Impact of mistletoe lectin binding in breast cancer.

Fritz P, Dippon J, Kierschke T, Siegle I, Möhring A, Moisa A, Mürdter TE.

Anticancer Res. 2004 Mar-Apr;24(2C):1187-92.

46.

Prognostic significance of transforming growth factor beta receptor II in estrogen receptor-negative breast cancer patients.

Buck MB, Fritz P, Dippon J, Zugmaier G, Knabbe C.

Clin Cancer Res. 2004 Jan 15;10(2):491-8.

Supplemental Content

Loading ...
Support Center